Stephanie M Downs-Canner

14PUBLICATIONS
16CO-AUTHORS
Autonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 29, 2025
Nipple Discharge and Pathologic Involvement of the Nipple-Areolar Complex: Reconsidering Guidelines for Nipple-Sparing Mastectomy.

Thomas Amburn, Sahar Farahani, Varadan Sevilimedu

|May 20, 2024
Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.

Sara P Myers, Varadan Sevilimedu, V Morgan Jones

|Oct 10, 2022
Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?

Nicole Knape, Ji-Hye Park, Chris B Agala

|May 13, 2022
Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer.

Selena J An, Emilie D Duchesneau, Paula D Strassle

|Apr 19, 2022
The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.

Alina M Hamilton, Amber N Hurson, Linnea T Olsson

|Apr 07, 2022
Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors.

Katherine A Hrebinko, Cindy L Bryce, Stephanie Downs-Canner

Pageof 3

Frequent Collaborators

3 joint publications

Paula D Strassle

2 joint publications

Philip Spanheimer

2 joint publications

Kristalyn K Gallagher

2 joint publications

David W Ollila